Related Experiment Video
Updated: Aug 15, 2026

Pull-down of Calmodulin-binding Proteins
Published on: January 23, 2012
[DREAM/Calsenilin/KChIP3: a new multifunctional protein in nervous system]
1Neuroscience Research Institute, Peking University, Key Laboratory of Neuroscience, Ministry of Education, Beijing 100083.
Abstract:
A newly found transcription factor-DREAM can bind specifically with downstream regulatory element of genes, such as PPD, Hrk and c-Fos, and repress gene expression. It represents the first known Ca2+ binding protein to function as a DNA-binding transcription regulator. This provides a new mechanism of Ca2+ dependent regulation of gene expression in addition to protein kinase/phosphatase signaling pathway. In fact, DREAM, calsenilin and KChIP3, which are identified by different laboratories, are the same protein. So DREAM is a multifunctional protein, including PS interacting protein, Kv4 regulatory protein and transcription factor. The distribution, function and regulation of DREAM, as well as relationship between DREAM and pain, are reviewed in the present article.
More Related Videos
Related Concept Videos
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

